Molecular Analysis for Therapy Choice (MATCH)
- Result Type
- clinical trial
This phase II trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas.
You are viewing results from Research and Clinical Trials.
7results found for:
This phase II trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas.
Status: Active, Recruiting
This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer.
Status: Active, Recruiting
This randomized phase II/III trial studies docetaxel, antiandrogen therapy, and radiation therapy to see how well it works compared with antiandrogen therapy.
Status: Active, Recruiting
Purpose of this study is to assess the safety and efficacy of pembrolizumab combination therapy in patients with metastatic castrate resistant prostate cancer.
Status: Active, Recruiting
The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer respond to treatment with rucaparib
Status: Active, Recruiting
The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of ipatasertib plus abiraterone and prednisone/prednisolone.
Status: Active, Recruiting
This Phase III, multicenter, randomized, open-label study will evaluate the safety and efficacy of atezolizumab (anti-programmed death-ligand 1 antibody)
Status: Active, Recruiting
Check-ups, screenings and sick visits for adults and children.
Expertise and advanced technologies in all areas of medicine.
For serious accidents, injuries and conditions that require immediate medical care.
After-hours, weekend and holiday services.
Convenient walk-in care clinics for your non-urgent health needs.